USP30 Gene - Ubiquitin Specific Peptidase 30

Mitochondrial deubiquitinase involved in mitophagy and Parkinson's disease

Gene Information Card

Symbol USP30
Full Name Ubiquitin specific peptidase 30
Gene Type protein coding
Chromosomal Location 6q14.1
NCBI Gene ID 84749 ncbi.nlm.nih.gov/gene/84749
Ensembl ID ENSG00000135094
UniProt ID Q70CQ3
OMIM ID 618073
HGNC ID 20085
Aliases FLJ12806, dJ337O18.4

Description

USP30 encodes a deubiquitinating enzyme localized to the outer mitochondrial membrane. It removes ubiquitin from mitochondrial proteins, counteracting Parkin-mediated mitophagy. USP30 is implicated in mitochondrial quality control, apoptosis, and Parkinson's disease. Its inhibition is a therapeutic target for Parkinson's and other mitochondrial disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Parkinson's disease USP30 negatively regulates mitophagy; increased activity may impair clearance of damaged mitochondria, contributing to dopaminergic neuron loss. Genetic association studies; functional assays in cell models (PMID: 25456121, 28934303)
Mitochondrial dysfunction Overexpression of USP30 reduces mitophagy, leading to accumulation of dysfunctional mitochondria; knockdown enhances mitophagy. Cell-based studies (PMID: 25456121)
Cancer USP30 expression may influence apoptosis and mitochondrial dynamics in tumor cells; potential role in chemoresistance. Expression profiling in cancer cell lines (COSMIC)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 5.2 Low
Heart 3.1 Low
Liver 2.4 Low
Kidney 4.0 Low
Testis 6.8 Medium
Skeletal Muscle 2.0 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 8.5 Cervical cancer cell line
HepG2 6.2 Liver cancer cell line
SH-SY5Y 7.8 Neuroblastoma cell line
MCF7 5.9 Breast cancer cell line
A549 4.8 Lung cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1Val) Missense Rare Potential loss of start codon, reduced protein expression
c.215C>T (p.Thr72Met) Missense Rare Unknown functional effect
c.340G>A (p.Gly114Ser) Missense Rare Unknown functional effect
c.512A>G (p.Tyr171Cys) Missense Rare Unknown functional effect
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations may impair deubiquitinase activity, leading to enhanced mitophagy and potential neuroprotection, but also could disrupt mitochondrial dynamics.

Gain of Function (GOF)

Gain-of-function mutations may increase USP30 activity, reducing mitophagy and contributing to mitochondrial dysfunction and Parkinson's disease.

Dominant Negative (DN)

Dominant-negative mutations could interfere with dimerization or substrate binding, reducing overall deubiquitinase activity.

Gene Ontology (GO)

• cysteine-type peptidase activity • ubiquitin-specific protease activity
• mitochondrial outer membrane • protein deubiquitination
• negative regulation of mitophagy • mitochondrial fusion

Pathways

Mitophagy (Parkin-mediated)
Ubiquitin-proteasome system
Mitochondrial quality control

Protein Summary

USP30 is a 517-amino acid protein with a catalytic domain characteristic of ubiquitin-specific proteases. It is anchored to the mitochondrial outer membrane via a transmembrane domain. USP30 specifically cleaves ubiquitin from mitochondrial proteins, including those tagged by Parkin, thereby opposing mitophagy. It also regulates mitochondrial fusion and apoptosis. Its expression is ubiquitous but low, with highest levels in testis and brain. USP30 is a promising drug target for Parkinson's disease and other mitochondrial disorders.

Related Products

Product name Cat.No. Species Gene ID
USP30 Knockout HEK293 Cell Line EDJ-KQ10187 Human 84749 Details Get a Quote
USP30 Knockout A-549 Cell Line EDJ-KQ37317 Human 84749 Details Get a Quote
USP30 Knockout HCT 116 Cell Line EDJ-KQ37318 Human 84749 Details Get a Quote
USP30 Knockout HeLa Cell Line EDJ-KQ37319 Human 84749 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: